Impact of Exercise on Immunometabolism in Multiple Sclerosis
Open Access
- 21 September 2020
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (9), 3038
- https://doi.org/10.3390/jcm9093038
Abstract
Multiple Sclerosis (MS) is a chronic, autoimmune condition characterized by demyelinating lesions and axonal degradation. Even though the cause of MS is heterogeneous, it is known that peripheral immune invasion in the central nervous system (CNS) drives pathology at least in the most common form of MS, relapse-remitting MS (RRMS). The more progressive forms’ mechanisms of action remain more elusive yet an innate immune dysfunction combined with neurodegeneration are likely drivers. Recently, increasing studies have focused on the influence of metabolism in regulating immune cell function. In this regard, exercise has long been known to regulate metabolism, and has emerged as a promising therapy for management of autoimmune disorders. Hence, in this review, we inspect the role of key immunometabolic pathways specifically dysregulated in MS and highlight potential therapeutic benefits of exercise in modulating those pathways to harness an anti-inflammatory state. Finally, we touch upon current challenges and future directions for the field of exercise and immunometabolism in MS.Funding Information
- Science Foundation Ireland (SFI/FRL/1063400)
This publication has 175 references indexed in Scilit:
- Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain ScansPLOS ONE, 2013
- HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cellsThe Journal of Experimental Medicine, 2011
- Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongationBiochemical Pharmacology, 2011
- The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2Nature Immunology, 2011
- Crossover trial of gabapentin and memantine as treatment for acquired nystagmusAnnals of Neurology, 2010
- mTOR signaling: At the crossroads of plasticity, memory and diseaseTrends in Neurosciences, 2010
- Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severityBiochemical and Biophysical Research Communications, 2009
- Exercise and the brain: something to chew onTrends in Neurosciences, 2009
- Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitisProceedings of the National Academy of Sciences of the United States of America, 2007
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002